Skip to main content

Table 6 The effects of Sumac supplementation on features of glycemic and lipid profile of adults with metabolic syndrome (with per protocol method) (n = 32)a

From: Effects of sumac supplementation on metabolic markers in adults with metabolic syndrome: a triple-blinded randomized placebo-controlled cross-over clinical trial

 

Sumac groupb

Control groupc

 
 

Baseline

6th week

Changed

Pe

Baseline

6th week

Changed

Pe

Pf

FBS (mg/dL)

109.4 ± 34.9

107.9 ± 32.6

-1.53 ± 15.83

0.58

107.2 ± 26.0

106.7 ± 27.7

-0.46 ± 20.93

0.90

0.82

Serum triglyceride (mg/dL)

179.8 ± 83.7

175.8 ± 81.2

-4.09 ± 48.75

0.63

171.5 ± 90.1

195.4 ± 113.5

23.93 ± 66.76

0.05

0.09

Total cholesterol (mg/dL)

166.7 ± 36.5

165.2 ± 32.1

-1.46 ± 27.84

0.76

158.9 ± 32.0

171.8 ± 44.0

12.90 ± 27.70

0.01

0.10

HDL-C (mg/dL)

43.2 ± 8.6

44.3 ± 10.9

1.09 ± 12.66

0.63

42.1 ± 9.3

43.6 ± 8.2

1.53 ± 11.96

0.47

0.89

LDL-C (mg/dL)

87.5 ± 31.4

85.8 ± 25.5

-1.74 ± 30.10

0.76

82.5 ± 27.4

89.1 ± 32.3

6.58 ± 23.97

0.13

0.33

  1. aReported values are means ± SD
  2. bIn the sumac group, participants received sumac capsules (500 mg/twice daily) for 6 weeks
  3. cIn the control group, participants received lactose capsules (500 mg/twice daily) for 6 weeks
  4. dCalculated by subsidizing baseline values from values of 6th week
  5. eObtained from paired t-test for comparison of with-in group differences
  6. fObtained from paired t-test for comparison of between-group differences